Streetbeat News

Regulatory

BRTX

BioRestorative Therapies (BRTX) announced that no dose limiting toxicity (DLT) was observed in the safety run-in segment of their study.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:38 am

BRTX

BioRestorative Therapies' Data Monitoring Committee has allowed the company's Chronic Lumbar Disc Disease study to continue unchanged.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:37 am

ACIU

AC Immune has been granted U.S. Patent #11684625 for compounds related to the treatment, alleviation, or prevention of disorders associated with tau aggregates.

Portfolio Pulse from Charles Gross

June 27, 2023 | 10:34 am

BRTX

BioRestorative Therapies Inc (NASDAQ:BRTX) has received unanimous approval from the independent Data Safety Monitoring Board (DSMB) to continue its ongoing Phase 2 trial for chronic lumbar disc disease treatment with no changes. The treated patients will receive BRTX-100, a product formulated from autologous hypoxic cultured mesenchymal stem cells and autologous platelet lysate.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 10:30 am

BDSX

Biodesix has completed enrollment of 5,000 non-small cell lung cancer patients in its INSIGHT study to further validate the utility of the VeriStrat test, a prognostic blood-based host immune classifier.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:16 am

IDCC

LNVGF

LNVGY

A UK court has ruled that Lenovo must pay interest on the original sum of $138.7 million, increasing its payment obligation to InterDigital to $184.9 million for a license to InterDigital's 3G, 4G, and 5G patents.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:01 am

VWAGY

Former Audi Chairman Rupert Stadler has been given a suspended sentence of one year and nine months by a German court for fraud by negligence in the 2015 Volkswagen diesel scandal. Stadler was fined €1.1 million ($1.20 million) towards the state treasury and non-governmental organizations. Volkswagen and Audi had admitted guilty of having used illegal software to bypass emissions tests.

Portfolio Pulse from Shivani Kumaresan

June 27, 2023 | 9:53 am

IMMX

Immatics Biotechnologies has been granted U.S. Patent #11685769 for peptides used in immunotherapy against cancers. This patent could potentially strengthen the company's position in the cancer immunotherapy market.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:39 am

TSLA

Tesla has been granted U.S. Patent #11685293 for an electronically controlled seat system with tilt-and-slide mode, which could enhance user experience and comfort in their vehicles.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:28 am

TSLA

Tesla has been granted U.S. Patent #11686384 for a method of making an electric drive unit having a gear shaft and rotor shaft with three bearings, potentially improving the efficiency and durability of its electric vehicles.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:25 am